🚨 NOW OPEN: Pre-Application for Rare Kidney Disease/Glomerular Disease Centers of Excellence! 🚨 Join exceptional institutions, clinics, and healthcare organizations to become designated Centers of Excellence. 🎯 What you'll gain: ✅ Access to premier fellowship programs ✅ Secure database platform for operational and research registry ✅ Exclusive director network meetings ✅ Free conference registration educational resources ✅ Clinical trial support services ✅ Population health dashboards 🏥 Perfect for: • Academic medical centers • Nephrology Clinics • Healthcare institutions serving rare kidney disease populations 📅 Timeline: Pre-applications open NOW | Framework release Fall 2025 Ready to elevate your rare kidney disease program? Apply today! 👇 ikgplk7aacm.typeform.com/to/… #RareKidneyDisease #GlomerularDisease #CentersOfExcellence #Nephrology #PatientCare

Accelerating drug discovery through innovative design: @jardine_meg, @SradhaKotwal, @LauraDember , @Suceena , Mohit Mathur, and @VladoPerkovic lead a vital breakout session on platform and basket trials in rare kidney diseases. #ClinicalTrials #RareDisease #Methodology #GlomConHawaii2026 #InnovativeDesign

When do you send the test, and what do you do with the result? @DrAnjayRastogi , Ali Gharavi, @pranavgarimella , Silvi Shah, Martin Pollak, and @SaynaNorouzi review VUS management, family screening, and patient counseling. #KidneyGenetics #Genomics #Nephrology #GlomConHawaii2026 #PrecisionMedicine

Join us for this week's GlomCon Sunday Seminar! Novel Antigens in Membranous Nephropathy: The Future Landscape in Management Presented by Dr. Laith Al-Rabadi June 14, 2026 | 8:00 AM PDT ID: 817 4374 4653 Passcode: 202122 Sign up 👉 bit.ly/signup-glomcon #GlomCon #Nephrology #KidneyDisease #MembranousNephropathy

Submit your next paper to Rare Kidney Diseases, official journal of @GlomCon. This new innovative journal is open for submissions: link.springer.com/journal/44… @springer1842

When the clone is invisible, how do you protect the kidney? @LadanZand , @PepaSolerR , @JZRenalPath , Fahmeedah Kamal, @NephRodby , and @d_r_waguespack lead a panel on clinico-pathological diagnosis, prognosis, and dissecting the new 2026 MGRS consensus, predictive AI, and clone-directed therapy. #MGRS #Nephrology #GlomConHawaii2026 #Hematology #Pathology

Who actually benefits from plasmapheresis? Amber Sanchez leads a two-part series of pheresis clinical workshop sessions. Part 1 focuses on the practical, bedside engineering of vascular access, replacement fluids, and circuit safety. Part 2 tackles the PEXIVAS paradox in ANCA vasculitis, post-transplant FSGS recurrence, and evidence-based indications. #Plasmapheresis #Nephrology #GlomConHawaii2026 #ClinicalEvidence

Risk based Induction, the PLEX question, maintenance, and histopathological guidance in ANCA vasculitis: John Niles, Cynthia Nast, Anette Bruchfeld, @BrixSilke , Arvind Madan, Peter Merkel, and @BetterCallSeeth lead the panel discussion. #ANCA #Vasculitis #Nephrology #GlomConHawaii2026 #Rheumatology

Day 2 of GlomCon China 2026 is underway in Guangzhou! 🌏 What a privilege to bring together 300 nephrologists, researchers, and fellows to advance the science and care of glomerular and rare kidney diseases. A heartfelt thank you to Professor Song Liu and Dean Meng Yu for their leadership and dedication in making this conference possible. Here's to a final day of learning, connection, and collaboration. 🙏 #GlomCon #GlomConChina2026 #Nephrology #KidneyDisease #GlomerularDisease #Guangzhou #RareKidneyDisease

🗣️ CALL FOR ABSTRACTS REMINDER 🗣️ We’re inviting posters and platform presentations that explore this year’s theme: "Advancing Kidney Disease Care: From Glomerular Science to Patient Outcomes" Accepted submissions will be notified by June 22 and may be featured as oral or poster presentations. Learn more 👉 glomconhawaii.org/abstract #GlomConHawaii #GlomCon

Deadline approaching: Submit your abstract to GlomCon Hawaii 2026 by June 10 📢 Accepted submissions will be notified by June 22 and may be featured as oral or poster presentations. Learn more 👉 glomconhawaii.org/abstract #GlomConHawaii #GlomCon

The clinical stacking of SGLT2 inhibitors, MRAs, and targeted immunotherapies. @brendonneuen , @erin_vaughan_ , @Nester1Carla , Michelle Hladunewich, @GlassockJ , and @nephrologista outline the long-term management checklist for chronic kidney disease. #LongitudinalCare #Nephrology #GlomConHawaii2026 #PrecisionMedicine

Join GlomCon this Sunday B and Plasma Cell-Targeting Therapies for Podocytopathies by Dr. Andrea Angeletti ID: 817 4374 4653 Passcode: 202122 Sign up 👉 bit.ly/signup-glomcon #GlomCon

Day 1 of the 49th Annual Columbia Renal Biopsy Course is packed with foundational and cutting-edge content! From Histopathology of the Glomerulus to current therapy of MCD & FSGS, Membranous Nephropathy updates, and C3G — this is where the latest in glomerular disease meets practical biopsy interpretation. Join us in NYC or virtually buff.ly/gn7mVBe #RenalBiopsy #Nephrology #CME @AgnesFogo @ColumbiaMed @ColumbiaKidney @glomcon

Starting complement inhibitors but not sure how to handle #vaccination and #antibiotics? 🚨 This is one of those practical questions that keeps coming up in clinic. Lets chat about it 😄 #ERA #RareKidneyDiseases @ERAkidney @GlomCon

How do we validate anti-PLA2R kinetics as a surrogate trial endpoint? @PolskiBarbara, Heather Reich, @fervenzaf , Manish Maski, Amit Sharma, and @VladoPerkovic debate the future of membranous nephropathy trial design. #Membranous #ClinicalTrials #GlomConHawaii2026 #PrecisionMedicine

📢 The Rare Disease And Nephrology Research Training (RADIANT) Program is now accepting applications! RADIANT Program is designed to teach foundational knowledge and skills in rare kidney disease research with a focus on clinical research in glomerular diseases. Applications close on June 24. 🔗For more information, visit us at glomcon.org/radiant-program #GlomCon #RADIANTProgram #education #research #training #nephrology #clinicalresearch

Not only the IgA1: the role of IgA2 in the IgA nephropathy pathogenesis 🔬 Great data presented by Dr. Run Li and Dr. Lei Jiang @GlomCon

AI feedback vs. human feedback >> we put it to the test ⭐️ At @GlomCon Fellowship, we care about how we teach, not just what we teach. So we studied one of the most overlooked skills: giving great feedback. See the details here👇 academic.oup.com/joneph/adva…

Confronting the STARMEN hangover and rituximab resistance in membranous nephropathy: @fervenzaf , @SethiRenalPath , @GlassockJ , @LadanZand , @PolskiBarbara , and @nephrologista break down biomarker-guided dosing and anti-B and anti-plasma cell strategies. #Membranous #Nephrology #GlomConHawaii2026 #Immunology #ClinicalReview